Prognosis is good for remote medication monitoring

A medtech company’s special bin for patients who self-inject medications at home is one of a range of ‘digital therapeutics’ that could help improve health outcomes for people with illnesses like cancer and rheumatoid arthritis

28th January, 2018
Jim Joyce, founder of HealthBeacon: ‘The whole issue of people doing what the doctor said is well known’ Maura Hickey

In November last year, medtech company HealthBeacon announced it was looking to raise €5 million, to bring its total funding to €8 million. By now, it is €2.5 million into its funding and will launch into another 11 markets by the end of 2018.

These kind of investments are common for companies with the next blockbuster drug or game changing medical device, but HealthBeacon, though only four years old, finds itself in one of the hottest new...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Hard Station: the strange world of tech embargoes

More Tech Brian Lloyd 2 months ago

Podcast: CWSI on securing remote workers during lockdown working

Podcast: Avaya on improving connectivity through the crisis

Tinkerer tailors a solution for property owners to save on water bills

More Tech Emmet Ryan 4 months ago